{"address1": "Av. Magalh\u00e3es de Castro, 4800", "address2": "240 Floor Continental Tower Building Bairro Cidade Jardim", "city": "S\u00e3o Paulo", "state": "SP", "zip": "05676-120", "country": "Brazil", "phone": "55 11 3627 4206", "website": "https://www.hyperapharma.com.br", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex \u0096 A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biot\u00f4nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Qu\u00edmica, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in S\u00e3o Paulo, Brazil.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Breno Toledo Pires de Oliveira", "title": "CEO & Director", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adalmario Ghovatto Satheler do Couto", "title": "Investor Relations Officer & CFO", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Carlos Roberto Scorsi", "age": 60, "title": "Chief Operating officer", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Juliana Aguinaga Dami\u00e3o Salem", "title": "Sr. Legal Officer & Director", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Joao Felipe Khamis Aguilar", "title": "Risks & Compliance Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Luiz Eduardo Sales Clavis", "title": "VP of Sales and Marketing & Director", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mauricio  Christovam", "title": "Sr. HR Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. H\u00e9lio  Segouras", "title": "Head of Consumer Health", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1682899200, "maxAge": 86400, "priceHint": 2, "previousClose": 7.745, "open": 7.64, "dayLow": 7.64, "dayHigh": 7.78, "regularMarketPreviousClose": 7.745, "regularMarketOpen": 7.64, "regularMarketDayLow": 7.64, "regularMarketDayHigh": 7.78, "dividendRate": 0.23, "dividendYield": 0.0298, "exDividendDate": 1680652800, "payoutRatio": 0.4432, "fiveYearAvgDividendYield": 3.86, "beta": 0.248637, "trailingPE": 14.407407, "volume": 1017, "regularMarketVolume": 1017, "averageVolume": 14030, "averageVolume10days": 4170, "averageDailyVolume10Day": 4170, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 4922919936, "fiftyTwoWeekLow": 6.81, "fiftyTwoWeekHigh": 9.6, "priceToSalesTrailing12Months": 0.6351335, "fiftyDayAverage": 7.5294, "twoHundredDayAverage": 8.2275, "trailingAnnualDividendRate": 1.231, "trailingAnnualDividendYield": 0.15894125, "currency": "USD", "enterpriseValue": 12821138432, "profitMargins": 0.21771, "floatShares": 403420218, "sharesOutstanding": 632766016, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00034000003, "impliedSharesOutstanding": 0, "bookValue": 17.076, "priceToBook": 0.45561022, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1680220800, "earningsQuarterlyGrowth": -0.027, "netIncomeToCommon": 1693048960, "trailingEps": 0.54, "enterpriseToRevenue": 1.654, "enterpriseToEbitda": 4.905, "52WeekChange": 0.093088865, "SandP52WeekChange": 0.046755195, "lastDividendValue": 0.059, "lastDividendDate": 1680652800, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "HYPMY", "underlyingSymbol": "HYPMY", "shortName": "HYPERA SA SPON ADR EA REPR 1 OR", "longName": "Hypera S.A.", "firstTradeDateEpochUtc": 1287149400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "213aea0c-9d58-3d38-99a4-6ab17a6d2fb4", "messageBoardId": "finmb_34669017", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.78, "recommendationKey": "none", "totalCash": 1087387008, "totalCashPerShare": 1.718, "ebitda": 2613744896, "totalDebt": 8995846144, "quickRatio": 1.121, "currentRatio": 1.96, "totalRevenue": 7751000064, "debtToEquity": 83.162, "revenuePerShare": 12.262, "returnOnAssets": 0.07317, "returnOnEquity": 0.16377, "grossProfits": 4761524000, "freeCashflow": -662532224, "operatingCashflow": 2028536064, "earningsGrowth": -0.029, "revenueGrowth": 0.137, "grossMargins": 0.63327, "ebitdaMargins": 0.33721, "operatingMargins": 0.32391, "financialCurrency": "BRL", "trailingPegRatio": null}